Markets

Market Valuation And Occam's Razor

An image of a stock chart
Credit: Shutterstock photo

By Jeff Miller :

Among competing hypotheses, the one with the fewest assumptions should be selected.- William of Occam

The use of this principle is valuable, but not completely determinative in science. It often has an important application in investing.

Let us consider two hypotheses.

  1. A method of valuing markets that relies upon backward-looking data, looks at replacement value, or depends upon some other fixed ratio. Put another way, all the most popular valuation metrics.
  2. A method that considers prospective earnings, expected inflation, and interest rates.

Method 1 has been wrong for many years. In fact, it has been mostly incorrect for decades. Method 2 has been on the right side of market moves, but still shows significant deviations. What can we learn from Occam's Razor?

Method 1

Since this method has been mostly wrong, many explanations have been offered. I think I left a few out, but you get the drift.

  1. Speculation
  2. Not recognizing "fundamental" risks - Euro collapse, China collapse, recession, Brexit, etc.
  3. Depending upon dubious earnings estimates
  4. Market is about to crash
  5. Method not good for market timing, but returns will be poor for the next5,7,10, 12, ? years
  6. Fed intervention - money printing and pumping up the market via QE
  7. Plunge protection team
  8. European Central Banks
  9. Suckers' Rally
  10. Myopia of the investment world - no efficient markets
  11. High Frequency Traders and Algorithms

Method 2

Since this method has been mostly right, little explanation is needed. The expected increase in market prices and multiples is consistent with the theory. It should continue for another 8-10%, and further if forward earnings increase.

Question

Should investors accept the complex and ever-changing explanations for Method 1? Or perhaps should they consider that the method itself is flawed?

See also How The S&P 500's P/E Ratios Can Levitate on seekingalpha.com

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Stocks